Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas

Journal of Neuro-Oncology

Volumn 76, Issue 2, 2006, Pages 115-127

  Bannykh, Sergei I ^a   Stolt, C Claus ^b   Kim, Jung ^a   Perry, Arie ^c   Wegner, Michael ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytoma; Expression; Oligodendroglioma; Pathogenesis; Pilocytic astrocytoma; SOX10

Indexed keywords

TRANSCRIPTION FACTOR SOX10;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN BIOPSY; CANCER DIAGNOSIS; CANCER GRADING; CHILD; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOMA; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTES; ASTROCYTOMA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GLIOMA; HIGH MOBILITY GROUP PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 31344457174     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-5533-x     Document Type: Article

References (72)

1. FG Davis V Kupelian S Freels B McCarthy T Surawicz 2001 Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups Neuro-oncology 3 152-158 1:STN:280:DC%2BD38%2Fit1GhtQ%3D%3D 11465395
2. LM DeAngelis 2001 Brain tumors N Engl J Med 344 114-123 10.1056/ NEJM200101113440207 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D 11150363
3. SW Coons PC Johnson BW Scheithauer AJ Yates DK Pearl 1997 Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas Cancer 79 1381-1393 10.1002/ (SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W 1:STN:280:ByiB3snks1E%3D 9083161
4. Kleihues P, Cavenee WK: International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Nervous System. IARC Press, Lyon, 2000, p 314
5. C Giannini BW Scheithauer AL Weaver PC Burger JM Kros S Mork MB Graeber S Bauserman JC Buckner J Burton R Riepe HD Tazelaar AG Nascimento T Crotty GL Keeney P Pernicone H Altermatt 2001 Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading J Neuropathol Exp Neurol 60 248-262 1:STN:280:DC%2BD3M7osVOitA%3D%3D 11245209
6. A Helseth SJ Mork 1989 Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology Apmis 97 547-555 1:STN:280:BiaB1cjgslE%3D 2736107
7. JG Cairncross DR Macdonald 1988 Successful chemotherapy for recurrent malignant oligodendroglioma Ann Neurol 23 360-364 10.1002/ana.410230408 1:STN:280:BieB2M%2FpsVI%3D 3382171
8. A Chahlavi A Kanner D Peereboom SM Staugaitis P Elson G Barnett 2003 Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: Preliminary results J Neurooncol 61 267-273 10.1023/ A:1022580610598 12675321
9. J Reifenberger G Reifenberger L Liu CD James W Wechsler VP Collins 1994 Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p Am J Pathol 145 1175-1190 1:CAS:528:DyaK2MXit1Wksb8%3D 7977648
10. MJ Bello PE Leone J Vaquero JM Campos de ME Kusak JL Sarasa A Pestana JA Rey 1995 Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors Int J Cancer 64 207-210 1:STN:280:ByqA2cjptVM%3D 7622310
11. JA Kraus J Koopmann P Kaskel D Maintz S Brandner J Schramm DN Louis OD Wiestler A Deimling von 1995 Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma J Neuropathol Exp Neurol 54 91-95 1:STN:280:ByqC3MvmtFM%3D 7815084
12. A Deimling von DN Louis K Ammon von I Petersen OD Wiestler BR Seizinger 1992 Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas Cancer Res 52 4277-4279
13. MJ Bello J Vaquero JM Campos de ME Kusak JL Sarasa J Saez-Castresana A Pestana JA Rey 1994 Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors Int J Cancer 57 172-175 1:CAS:528:DyaK2MXhsFyktg%3D%3D 8157354
14. A Perry 2001 Oligodendroglial neoplasms: Current concepts, misconceptions, and folklore Adv Anat Pathol 8 183-199 1:STN:280:DC%2BD38%2FhvF2qtA%3D%3D 11444508
15. JS Smith B Alderete Y Minn TJ Borell A Perry G Mohapatra SM Hosek D Kimmel J O'Fallon A Yates BG Feuerstein PC Burger BW Scheithauer RB Jenkins 1999 Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype Oncogene 18 4144-4152 1:CAS:528:DyaK1MXkvFChtLk%3D 10435596
16. Y Ino MC Zlatescu H Sasaki DR Macdonald AO Stemmer-Rachamimov S Jhung DA Ramsay A Deimling von DN Louis JG Cairncross 2000 Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss J Neurosurg 92 983-990 1:STN:280:DC%2BD3c3ps1Sluw%3D%3D 10839259
17. A Perry CE Fuller R Banerjee DJ Brat BW Scheithauer 2003 Ancillary FISH analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics Front Biosci 8 1-9
18. JG Cairncross K Ueki MC Zlatescu DK Lisle DM Finkelstein RR Hammond JS Silver PC Stark DR Macdonald Y Ino DA Ramsay DN Louis 1998 Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 1473-1479 10.1093/jnci/90.19.1473
19. Y Ino RA Betensky MC Zlatescu H Sasaki DR Macdonald AO Stemmer-Rachamimov DA Ramsay JG Cairncross DN Louis 2001 Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis Clin Cancer Res 7 839-845
20. MJ den Bent van LH Looijenga K Langenberg W Dinjens W Graveland L Uytdewilligen PA Sillevis Smitt RB Jenkins JM Kros 2003 Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features Cancer 97 1276-1284
21. JS Smith I Tachibana HK Lee J Qian U Pohl HW Mohrenweiser TJ Borell SM Hosek CL Soderberg A Deimling von A Perry BW Scheithauer DN Louis RB Jenkins 2000 Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers Genes Chromosomes Cancer 29 16-25 10.1002/ 1098-2264(2000)9999:9999<::AID-GCC1007>3.3.CO;2-9 1:CAS:528:DC%2BD3cXmtVCis78%3D 10918389
22. PC Burger AY Minn JS Smith TJ Borell AE Jedlicka BK Huntley PT Goldthwaite RB Jenkins BG Feuerstein 2001 Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma.A study of paraffin-embedded sections Mod Pathol 14 842-853 10.1038/ modpathol.3880400 1:STN:280:DC%2BD3MrhtVaisA%3D%3D 11557779
23. J Felsberg A Erkwoh MC Sabel L Kirsch R Fimmers B Blaschke U Schlegel J Schramm OD Wiestler G Reifenberger 2004 Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival Brain Pathol 14 121-130 1:CAS:528:DC%2BD2cXkvFCgs7Y%3D 15193024
24. Y Nakagawa E Perentes LJ Rubinstein 1986 Immunohistochemical characterization of oligodendrogliomas: An analysis of multiple markers Acta Neuropathol 72 15-22 10.1007/BF00687942 1:STN:280:BiiC2M3isFM%3D 2435103
25. CC Sung R Collins J Li DK Pearl SW Coons BW Scheithauer PC Johnson AJ Yates 1996 Glycolipids and myelin proteins in human oligodendrogliomas Glycoconj J 13 433-443 10.1007/BF00731476 1:CAS:528:DyaK28Xjs1Gjtr4%3D 8781974
26. PG Kennedy BA Watkins DG Thomas MD Noble 1987 Antigenic expression by cells derived from human gliomas does not correlate with morphological classification Neuropathol Appl Neurobiol 13 327-347 1:STN:280:BieD28nisFc%3D 3317103
27. Y Shoshan A Nishiyama A Chang S Mork GH Barnett JK Cowell BD Trapp SM Staugaitis 1999 Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors Proc Natl Acad Sci USA 96 10361-10366 10.1073/pnas.96.18.10361 1:CAS:528:DyaK1MXlvFentrY%3D 10468613
28. QR Lu D Yuk JA Alberta Z Zhu I Pawlitzky J Chan AP McMahon CD Stiles DH Rowitch 2000 Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system Neuron 25 317-329 10.1016/S0896-6273(00)80897-1 1:CAS:528:DC%2BD3cXhslOktrs%3D 10719888
29. H Takebayashi S Yoshida M Sugimori H Kosako R Kominami M Nakafuku Y Nabeshima 2000 Dynamic expression of basic helix-loop-helix Olig family members: Implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3 Mech Dev 99 143-148 10.1016/S0925-4773(00)00466-4 1:CAS:528:DC%2BD3cXot1yit74%3D 11091082
30. H Takebayashi Y Nabeshima S Yoshida O Chisaka K Ikenaka 2002 The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages Curr Biol 12 1157-1163 10.1016/ S0960-9822(02)00926-0 1:CAS:528:DC%2BD38XlsVyjsbk%3D 12121626
31. M Xin T Yue Z Ma FF Wu A Gow QR Lu 2005 Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice J Neurosci 25 1354-1365 1:CAS:528:DC%2BD2MXhs1Kmur0%3D 15703389
32. HA Arnett SP Fancy JA Alberta C Zhao SR Plant S Kaing CS Raine DH Rowitch RJ Franklin CD Stiles 2004 bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS Science 306 2111-2115 10.1126/science.1103709 1:CAS:528:DC%2BD2cXhtVOjsLrN 15604411
33. QR Lu T Sun Z Zhu N Ma M Garcia CD Stiles DH Rowitch 2002 Common developmental requirement for Olig function indicates a motor neuron/ oligodendrocyte connection Cell 109 75-86 10.1016/S0092-8674(02)00678-5 1:CAS:528:DC%2BD38XjtVOntLw%3D 11955448
34. Q Zhou DJ Anderson 2002 The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification Cell 109 61-73 10.1016/ S0092-8674(02)00677-3 1:CAS:528:DC%2BD38XjtVOntL8%3D 11955447
35. K Kuhlbrodt B Herbarth E Sock I Hermans-Borgmeyer M Wegner 1998 Sox10, a novel transcriptional modulator in glial cells J Neurosci 18 237-250 1:CAS:528:DyaK1cXjtVOjsA%3D%3D 9412504
36. EM Southard-Smith L Kos WJ Pavan 1998 Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model Nat Genet 18 60-64 10.1038/ng0198-60 1:STN:280:DyaK1c%2FosFyksw%3D%3D 9425902
37. S Britsch DE Goerich D Riethmacher RI Peirano M Rossner KA Nave C Birchmeier M Wegner 2001 The transcription factor Sox10 is a key regulator of peripheral glial development Genes Dev 15 66-78 10.1101/ gad.186601 1:CAS:528:DC%2BD3MXhvVKhu7w%3D 11156606
38. B Herbarth V Pingault N Bondurand K Kuhlbrodt I Hermans-Borgmeyer A Puliti N Lemort M Goossens M Wegner 1998 Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease Proc Natl Acad Sci USA 95 5161-5165 10.1073/pnas.95.9.5161 1:CAS:528:DyaK1cXivV2jsbY%3D 9560246
39. CC Stolt S Rehberg M Ader P Lommes D Riethmacher M Schachner U Bartsch M Wegner 2002 Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10 Genes Dev 16 165-170 10.1101/ gad.215802 1:CAS:528:DC%2BD38Xos1ersQ%3D%3D 11799060
40. M Wegner 2001 Expression of transcription factors during oligodendroglial development Microsc Res Tech 52 746-752 10.1002/ jemt.1059 1:CAS:528:DC%2BD3MXisFSnur0%3D 11276127
41. RI Peirano DE Goerich D Riethmacher M Wegner 2000 Protein zero gene expression is regulated by the glial transcription factor Sox10 Mol Cell Biol 20 3198-3209 10.1128/MCB.20.9.3198-3209.2000 1:CAS:528:DC%2BD3cXivFSrsro%3D 10757804
42. N Bondurand M Girard V Pingault N Lemort O Dubourg M Goossens 2001 Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10 Hum Mol Genet 10 2783-2795 10.1093/hmg/10.24.2783 1:CAS:528:DC%2BD3MXptlKrsLY%3D 11734543
43. V Pingault N Bondurand K Kuhlbrodt DE Goerich MO Prehu A Puliti B Herbarth I Hermans-Borgmeyer E Legius G Matthijs J Amiel S Lyonnet I Ceccherini G Romeo JC Smith AP Read M Wegner M Goossens 1998 SOX10 mutations in patients with Waardenburg-Hirschsprung disease Nat Genet 18 171-173 10.1038/ng0298-171 1:CAS:528:DyaK1cXos1ahtw%3D%3D 9462749
44. K Inoue M Khajavi T Ohyama S Hirabayashi J Wilson JD Reggin P Mancias IJ Butler MF Wilkinson M Wegner JR Lupski 2004 Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations Nat Genet 36 361-369 10.1038/ng1322 1:CAS:528:DC%2BD2cXis1ahsb4%3D 15004559
45. QR Lu JK Park E Noll JA Chan J Alberta D Yuk MG Alzamora DN Louis CD Stiles DH Rowitch PM Black 2001 Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors Proc Natl Acad Sci USA 98 10851-10856 1:CAS:528:DC%2BD3MXntVGmsb8%3D 11526205
46. Y Marie M Sanson K Mokhtari P Leuraud M Kujas JY Delattre J Poirier B Zalc K Hoang-Xuan 2001 OLIG2 as a specific marker of oligodendroglial tumour cells Lancet 358 298-300 10.1016/S0140-6736(01)05499-X 1:CAS:528:DC%2BD3MXlslCjsLk%3D 11498220
47. CC Stolt P Lommes E Sock MC Chaboissier A Schedl M Wegner 2003 The Sox9 transcription factor determines glial fate choice in the developing spinal cord Genes Dev 17 1677-1689 10.1101/gad.259003 1:CAS:528:DC%2BD3sXlsV2ru7k%3D 12842915
48. CE Fuller RE Schmidt KA Roth PC Burger BW Scheithauer R Banerjee K Trinkaus R Lytle A Perry 2003 Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features J Neuropathol Exp Neurol 62 1118-1128 14656070
49. Bailey P, Cushing H: A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. J.B. Lippincott Company, Philadelphia, London, 1926, 175
50. LB Rorke 1997 Pathologic diagnosis as the gold standard Cancer 79 665-667 10.1002/ (SICI)1097-0142(19970215)79:4<665::AID-CNCR1>3.0.CO;2-D 1:STN:280:ByiC2sjhsFQ%3D 9024702
51. L Tenenbaum E Teugels Z Dogusan V Avellana-Adalid EL Hooghe-Peters 1996 Plastic phenotype of human oligodendroglial tumour cells in vitro Neuropathol Appl Neurobiol 22 302-310 1:STN:280:ByiD38bksFc%3D 8875464
52. A Ohnishi H Sawa M Tsuda Y Sawamura T Itoh Y Iwasaki K Nagashima 2003 Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas J Neuropathol Exp Neurol 62 1052-1059 1:CAS:528:DC%2BD3sXos1Cqtrs%3D 14575240
53. C Bouvier C Bartoli L Aguirre-Cruz I Virard C Colin C Fernandez J Gouvernet D Figarella-Branger 2003 Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells J Neurosurg 99 344-350 1:CAS:528:DC%2BD3sXmslamtbc%3D 12924709
54. KL Ligon JA Alberta AT Kho J Weiss MR Kwaan CL Nutt DN Louis CD Stiles DH Rowitch 2004 The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas J Neuropathol Exp Neurol 63 499-509 1:CAS:528:DC%2BD2cXlt1elsr8%3D 15198128
55. L Aguirre-Cruz K Mokhtari K Hoang-Xuan Y Marie E Criniere S Taillibert M Lopes JY Delattre M Sanson 2004 Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors J Neurooncol 67 265-271 10.1023/ B:NEON.0000024190.56750.81 15164981
56. B Azzarelli L Miravalle R Vidal 2004 Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors J Neuropathol Exp Neurol 63 170-179 1:CAS:528:DC%2BD2cXhvVWhsLk%3D 14989603
57. H Yokoo S Nobusawa H Takebayashi K Ikenaka K Isoda M Kamiya A Sasaki J Hirato Y Nakazato 2004 Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas Am J Pathol 164 1717-1725 1:CAS:528:DC%2BD2cXns1Gqu70%3D 15111318
58. K Mokhtari S Paris L Aguirre-Cruz N Privat E Criniere Y Marie JJ Hauw M Kujas D Rowitch K Hoang-Xuan JY Delattre M Sanson 2005 Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification Neuropathol Appl Neurobiol 31 62-69 10.1111/j.1365-2990.2004.00612.x 1:CAS:528:DC%2BD2MXitVamsLg%3D 15634232
59. MJ Riemenschneider TH Koy G Reifenberger 2004 Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas Acta Neuropathol (Berl) 107 277-282 1:CAS:528:DC%2BD2cXht1aiuro%3D
60. D Figarella-Branger L Daniel P Andre S Guia W Renaud G Monti E Vivier G Rougon 1999 The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas Am J Pathol 155 1261-1269 1:CAS:528:DyaK1MXntFWmt7k%3D 10514408
61. Burger PC, Scheithauer BW, Vogel FS: Surgical Pathology of the Nervous System and its Coverings. Churchill Livingstone, New York, 2002, p 657
62. C Decaestecker I Camby L Gordower O Dewitte P Cras JJ Martin JL Pasteels P Ham Van J Brotchi R Kiss I Salmon 1998 Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy J Neuropathol Exp Neurol 57 791-802 1:STN:280:DyaK1czosFCnug%3D%3D 9720494
63. J He K Mokhtari M Sanson Y Marie M Kujas S Huguet P Leuraud L Capelle JY Delattre J Poirier K Hoang-Xuan 2001 Glioblastomas with an oligodendroglial component: A pathological and molecular study J Neuropathol Exp Neurol 60 863-871 1:CAS:528:DC%2BD3MXnt1Snt7c%3D 11556543
64. K Husemann M Wolter R Buschges J Bostrom M Sabel G Reifenberger 1999 Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors J Neuropathol Exp Neurol 58 1041-1050 1:CAS:528:DyaK1MXmsl2gu74%3D 10515227
65. T Iuchi H Namba Y Iwadate T Shishikura H Kageyama Y Nakamura M Ohira A Yamaura K Osato S Sakiyama A Nakagawara 2002 Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors Genes Chromosomes Cancer 35 170-175 10.1002/gcc.10080 1:CAS:528:DC%2BD38XntVyjtL4%3D 12203781
66. N Hashimoto M Murakami Y Takahashi M Fujimoto J Inazawa K Mineura 2003 Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p Cancer 97 2254-2261 10.1002/cncr.11322 1:CAS:528:DC%2BD3sXjvVSjs7Y%3D 12712480
67. JW Jeuken A Deimling von P Wesseling 2004 Molecular pathogenesis of oligodendroglial tumors J Neurooncol 70 161-181 10.1007/ s11060-004-2748-1 15674476
68. JE Rosenberg DK Lisle JA Burwick K Ueki A Deimling von HW Mohrenweiser DN Louis 1996 Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval Oncogene 13 2483-2485 1:CAS:528:DyaK2sXnvFWk 8957092
69. RM Wolf N Draghi X Liang C Dai L Uhrbom C Eklof B Westermark EC Holland MD Resh 2003 p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3 Genes Dev 17 476-487 10.1101/gad.1040003 1:CAS:528:DC%2BD3sXhslCqtbc%3D 12600941
70. A Mukasa K Ueki S Matsumoto S Tsutsumi R Nishikawa T Fujimaki A Asai T Kirino H Aburatani 2002 Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p Oncogene 21 3961-3968 10.1038/sj.onc.1205495 1:CAS:528:DC%2BD38XkslWqt7Y%3D 12037678
71. A Mukasa K Ueki X Ge S Ishikawa T Ide T Fujimaki R Nishikawa A Asai T Kirino H Aburatani 2004 Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss Brain Pathol 14 34-42 1:CAS:528:DC%2BD2cXhvVKiu7c%3D 14997935
72. TN Ignatova VG Kukekov ED Laywell ON Suslov FD Vrionis DA Steindler 2002 Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro Glia 39 193-206 10.1002/ glia.10094 12203386